20 May 2026
20 May 2026
The UK has received a supply of favipiravir from the Japanese government to aid Hantavirus preparedness.
The integration helps researchers understand disease biology and uncover biomarkers for developing new medicines.
As China continues to inch ahead of competition in terms of trial initiations, immunology and metabolic disease trials attract sponsor eyes.
Hansa will receive €110m upfront and a further €5m once the European Medicines Agency accepts Idefirix’s full approval filing.
Parabilis is set to receive $125m, including a $50m upfront payment and a $75m investment, subject to agreed conditions.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
